The purpose of email discussions is to share information about medicines and practice in NSW public hospitals. NSW TAG members are encouraged to respond to email discussion requests for information. However, it should be noted that information is only a current snapshot at the time the response is sent. The responses received are only representative of the hospitals participating in the discussion at the time (which may be small depending on the topic) and do not indicate a complete picture of current practices. It is recommended that email discussion topics are regularly brought to the attention of DTC meetings as they are likely to facilitate discussion of contemporary and emerging medicines and practice.
Open email discussions
Please provide email discussions responses to NSW TAG
Completed email discussions can be found here (members only).
Access to completed email discussions is only available to NSW TAG members. Please note, members should not share or pass on identifiable information to non-NSW TAG members. Non-NSW TAG members who are interested in an email discussion topic may obtain de-identified email discussions by contacting NSW TAG at email@example.com
A list of the recently completed email discussions is shown below.
Recently Completed Email Discussions
- Formulary status of carbetocin
- Ketamine in acute pain
- Topical anaesthetics on formulary
- Use of coloured patient ID bands
- Local policy for Medicines Access Programs approvals
- Navigating the PBS
- Dual antiplatelet dispensing post PCI
- Use of povidone iodine in theatres
- Nifedipine for tocolysis
- Managing medication shortages
- 2020 Vaccine management issues
- COVID-19 guideline development for handling patient’s own and hospital issued medications
- Nicotine replacement therapy inhalers on formulary
- Rapid sequence intubation (RSI) kits for COVID-19 patients
- Use of very high cost medicines in those transitioning from paediatric to adult hospitals
Click here to access the email discussions running list of topics (last updated 04/09/2020).
Click here to access the completed email discussions page (members only).
Page last updated 9 September 2020